Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-13-000835
Filing Date
2013-02-22
Accepted
2013-02-22 14:39:09
Documents
9
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q alrx_10q.htm 10-Q 546439
2 CERTIFICATION alrx_ex311.htm EX-31.1 22190
3 CERTIFICATION alrx_ex321.htm EX-32.1 6885
  Complete submission text file 0001477932-13-000835.txt   2219808

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT alrx-20121231.xml EX-101.INS 185789
5 XBRL TAXONOMY EXTENSION SCHEMA alrx-20121231.xsd EX-101.SCH 36191
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alrx-20121231_cal.xml EX-101.CAL 31532
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alrx-20121231_def.xml EX-101.DEF 47418
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE alrx-20121231_lab.xml EX-101.LAB 197744
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alrx-20121231_pre.xml EX-101.PRE 104939
Mailing Address 31/F, TOWER ONE, TIMES SQUARE 1 MATHESON STREET CAUSEWAY BAY K3 31F
Business Address 31/F, TOWER ONE, TIMES SQUARE 1 MATHESON STREET CAUSEWAY BAY K3 31F (852) 2824 8716
ALPHARX INC (Filer) CIK: 0001114936 (see all company filings)

EIN.: 980177440 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-30813 | Film No.: 13633807
SIC: 2834 Pharmaceutical Preparations